State Street’s Firefly Neuroscience AIFF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$101K Buy
46,299
+22,900
+98% +$28.5K ﹤0.01% 4022
2025
Q4
$20.5K Hold
23,399
﹤0.01% 4243
2025
Q3
$68.1K Hold
23,399
﹤0.01% 4111
2025
Q2
$66.2K Hold
23,399
﹤0.01% 4047
2025
Q1
$92K Buy
23,399
+9,500
+68% +$43.7K ﹤0.01% 3987
2024
Q4
$36.8K Buy
+13,899
New +$43.1K ﹤0.01% 4154
2023
Q4
Sell
-1,300
Closed -$9.75K 4504
2023
Q3
$9.75K Buy
1,300
+483
+59% +$4.95K ﹤0.01% 4510
2023
Q2
$7.84K Hold
817
﹤0.01% 4653
2023
Q1
$7.09K Hold
817
﹤0.01% 4760
2022
Q4
$11.8K Hold
817
﹤0.01% 4790
2022
Q3
$23K Hold
817
﹤0.01% 4811
2022
Q2
$33K Hold
817
﹤0.01% 4802
2022
Q1
$129K Buy
+817
New +$110K ﹤0.01% 4556

Other funds holding AIFF

State Street's AIFF Position: Q1 2026 in Review

State Street increased its Firefly Neuroscience (AIFF) stake by 98% in Q1 2026, buying an estimated $28.5K and bringing the position to 46,299 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #4022.

State Street first reported a position in AIFF in Q1 2022 and has held it in 13 quarters since. The position peaked at $129K in Q1 2022. 23 funds tracked by Wall St. Rank hold AIFF as of Q1 2026.

  • State Street held 46,299 shares of Firefly Neuroscience worth $101K as of Q1 2026.
  • State Street bought 22,900 Firefly Neuroscience shares in Q1 2026, an estimated $28.5K.
  • Firefly Neuroscience made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4022 holding.
  • State Street first reported a position in Firefly Neuroscience in Q1 2022 and has held it in 13 quarters since.
  • State Street's Firefly Neuroscience position peaked at $129K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.